American Association for Cancer Research
10780432ccr121008-sup-fig3.pdf (48.99 kB)

Supplementary Figure 3 from Decreased NK Cells in Patients with Head and Neck Cancer Determined in Archival DNA

Download (48.99 kB)
journal contribution
posted on 2023-03-31, 17:17 authored by William P. Accomando, John K. Wiencke, E. Andres Houseman, Rondi A. Butler, Shichun Zheng, Heather H. Nelson, Karl T. Kelsey

PDF file - 48K, Demethylation of a DNA region in NKp46 in control and HNSCC patient bloods assessed by qMSP



Purpose: Natural killer (NK) cells are a key element of the innate immune system implicated in human cancer. To examine NK cell levels in archived bloods from a study of human head and neck squamous cell carcinoma (HNSCC), a new DNA-based quantification method was developed.Experimental Design: NK cell-specific DNA methylation was identified by analyzing DNA methylation and mRNA array data from purified blood leukocyte subtypes (NK, T, B, monocytes, granulocytes), and confirmed via pyrosequencing and quantitative methylation specific PCR (qMSP). NK cell levels in archived whole blood DNA from 122 HNSCC patients and 122 controls were assessed by qMSP.Results: Pyrosequencing and qMSP confirmed that a demethylated DNA region in NKp46 distinguishes NK cells from other leukocytes, and serves as a quantitative NK cell marker. Demethylation of NKp46 was significantly lower in HNSCC patient bloods compared with controls (P < 0.001). Individuals in the lowest NK tertile had over 5-fold risk of being a HNSCC case, controlling for age, gender, HPV16 status, cigarette smoking, alcohol consumption, and BMI (OR = 5.6, 95% CI, 2.0 to 17.4). Cases did not show differences in NKp46 demethylation based on tumor site or stage.Conclusions: The results of this study indicate a significant depression in NK cells in HNSCC patients that is unrelated to exposures associated with the disease. DNA methylation biomarkers of NK cells represent an alternative to conventional flow cytometry that can be applied in a wide variety of clinical and epidemiologic settings including archival blood specimens. Clin Cancer Res; 18(22); 6147–54. ©2012 AACR.

Usage metrics

    Clinical Cancer Research



    Ref. manager